Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.43B |
| 2 |
Chevron
CVX
|
+$314M |
| 3 |
ExxonMobil
XOM
|
+$282M |
| 4 |
Tesla
TSLA
|
+$253M |
| 5 |
Warner Bros
WBD
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$278M |
| 2 |
CERN
Cerner Corp
CERN
|
+$275M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$149M |
| 4 |
Baidu
BIDU
|
+$137M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Cullinan Oncology
CGEM
$1.13B
| $72K | ﹤0.01% |
5,644
-875
| -13% | -$9.92K |
|
2927
DHT Holdings
DHT
$2.98B
| $72K | ﹤0.01% |
11,737
-2,594
| -18% | -$15.2K |
|
2928
Erasca
ERAS
$6.29B
| $72K | ﹤0.01% |
13,094
+623
| +5% | +$4.08K |
|
|
TRHC
2929
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $72K | ﹤0.01% |
27,925
-175,423
| -86% | -$658K |
|
|
AKRO
2930
DELISTED
Akero Therapeutics
AKRO
| $71K | ﹤0.01% |
7,478
+569
| +8% | +$5.93K |
|
2931
Hagerty
HGTY
$1.39B
| $71K | ﹤0.01% |
+6,213
| New | +$62.9K |
|
2932
Rigel Pharmaceuticals
RIGL
$753M
| $71K | ﹤0.01% |
6,264
-458
| -7% | -$9.2K |
|
|
OBE
2933
Obsidian Energy
OBE
$668M
| $70K | ﹤0.01% |
+9,123
| New | +$80.7K |
|
2934
Target Hospitality
TH
$1.65B
| $70K | ﹤0.01% |
12,221
+9,927
| +433% | +$62.1K |
|
|
BNFT
2935
DELISTED
Benefitfocus, Inc.
BNFT
| $70K | ﹤0.01% |
8,931
+291
| +3% | +$2.87K |
|
|
FMTX
2936
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $70K | ﹤0.01% |
10,187
+3,670
| +56% | +$25.8K |
|
2937
Bioventus
BVS
$1.19B
| $69K | ﹤0.01% |
10,121
+7,364
| +267% | +$75.1K |
|
|
DCBO
2938
Docebo
DCBO
$551M
| $69K | ﹤0.01% |
2,393
+243
| +11% | +$9.22K |
|
2939
Scholar Rock
SRRK
$6.31B
| $69K | ﹤0.01% |
12,552
+736
| +6% | +$5.29K |
|
2940
Stoke Therapeutics
STOK
$2.08B
| $69K | ﹤0.01% |
5,242
-39
| -0.7% | -$592 |
|
2941
Vital Farms
VITL
$543M
| $69K | ﹤0.01% |
7,842
+1,432
| +22% | +$15.3K |
|
|
VLDR
2942
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $69K | ﹤0.01% |
71,750
+24,868
| +53% | +$43K |
|
2943
Traeger
COOK
$166M
| $68K | ﹤0.01% |
317
+149
| +89% | +$41.5K |
|
2944
1-800-Flowers.com
FLWS
$255M
| $68K | ﹤0.01% |
7,116
-3,794
| -35% | -$41.9K |
|
2945
Monte Rosa Therapeutics
GLUE
$1.36B
| $67K | ﹤0.01% |
6,924
+1,931
| +39% | +$19.4K |
|
2946
Vera Therapeutics
VERA
$2.33B
| $67K | ﹤0.01% |
4,898
+3,591
| +275% | +$62.7K |
|
2947
4D Molecular Therapeutics
FDMT
$560M
| $66K | ﹤0.01% |
9,387
+1,147
| +14% | +$11.2K |
|
|
TCS
2948
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $66K | ﹤0.01% |
703
-86
| -11% | -$9.76K |
|
|
VZIO
2949
DELISTED
VIZIO Holding Corp.
VZIO
| $66K | ﹤0.01% |
+9,637
| New | +$78.8K |
|
2950
Intapp
INTA
$2.96B
| $65K | ﹤0.01% |
4,403
+719
| +20% | +$15.1K |
|
Similar funds
Legal & General Group's Q2 2022 Portfolio in Review
As of Q2 2022, Legal & General Group held 3,787 positions worth $283B, down 14% from $329B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group's Q2 2022 filing shows 222 new, 1,979 increased, 1,147 reduced and 274 closed positions. Its largest new stake was Samsara: 1,199,080 shares worth $13.4M. The largest sale was AT&T, an estimated $278M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2022 buy was Samsara: 1,199,080 shares worth $13.4M.
- Legal & General Group added most to Apple in Q2 2022, an estimated $1.43B increase.
- Legal & General Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $278M.
- Legal & General Group fully exited Cerner Corp in Q2 2022, selling an estimated $275M.
- Legal & General Group's ten largest holdings make up 22% of its $283B portfolio in Q2 2022.
- Legal & General Group opened 222 new positions and closed 274 in Q2 2022.
- Legal & General Group's portfolio value fell 14% quarter-over-quarter to $283B.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.